Aurélien Dupré

2.4k total citations
96 papers, 1.0k citations indexed

About

Aurélien Dupré is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Aurélien Dupré has authored 96 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hepatology, 45 papers in Surgery and 42 papers in Oncology. Recurrent topics in Aurélien Dupré's work include Hepatocellular Carcinoma Treatment and Prognosis (46 papers), Ultrasound and Hyperthermia Applications (20 papers) and Pancreatic and Hepatic Oncology Research (17 papers). Aurélien Dupré is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (46 papers), Ultrasound and Hyperthermia Applications (20 papers) and Pancreatic and Hepatic Oncology Research (17 papers). Aurélien Dupré collaborates with scholars based in France, United Kingdom and United States. Aurélien Dupré's co-authors include Hassan Malik, Michel Rivoire, Johan Gagnière, David Melodelima, Emmanuel Buc, Patrice Peyrat, Robert Jones, Stephen W. Fenwick, Rafael Díaz-Nieto and Graeme J. Poston and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.

In The Last Decade

Aurélien Dupré

91 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurélien Dupré France 17 562 481 423 212 147 96 1.0k
Vittorio Pedicini Italy 19 314 0.6× 546 1.1× 453 1.1× 450 2.1× 51 0.3× 65 1.3k
Hideyuki Ike Japan 19 917 1.6× 757 1.6× 319 0.8× 376 1.8× 31 0.2× 82 1.3k
Steven Yevich United States 14 218 0.4× 305 0.6× 235 0.6× 181 0.9× 66 0.4× 53 661
Tsuyoshi Shoji Japan 20 385 0.7× 552 1.1× 91 0.2× 550 2.6× 94 0.6× 92 1.3k
Mitsuhiro Asakuma Japan 21 507 0.9× 763 1.6× 575 1.4× 429 2.0× 45 0.3× 84 1.3k
F. Löhe Germany 18 237 0.4× 637 1.3× 297 0.7× 366 1.7× 51 0.3× 40 1.1k
Giammauro Berardi Italy 24 721 1.3× 949 2.0× 973 2.3× 560 2.6× 49 0.3× 94 1.6k
Danny Yakoub United States 21 535 1.0× 860 1.8× 280 0.7× 712 3.4× 39 0.3× 81 1.5k
F. Pigneur France 19 278 0.5× 387 0.8× 354 0.8× 159 0.8× 88 0.6× 57 1.4k
Chandana Lall United States 20 199 0.4× 473 1.0× 197 0.5× 290 1.4× 59 0.4× 67 1.1k

Countries citing papers authored by Aurélien Dupré

Since Specialization
Citations

This map shows the geographic impact of Aurélien Dupré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélien Dupré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélien Dupré more than expected).

Fields of papers citing papers by Aurélien Dupré

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélien Dupré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélien Dupré. The network helps show where Aurélien Dupré may publish in the future.

Co-authorship network of co-authors of Aurélien Dupré

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélien Dupré. A scholar is included among the top collaborators of Aurélien Dupré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélien Dupré. Aurélien Dupré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lefèvre, Jérémie H., Olivier Dubreuil, Raphaël Colle, et al.. (2025). Neoadjuvant pembrolizumab with a watch‑and‑wait strategy for localized MSI/dMMR colon cancer: Study protocol for a randomized GERCOR 109 – PRODIGE 84 phase II trial (PREMICES). Digestive and Liver Disease. 58(1). 51–55.
2.
Dupré, Aurélien, et al.. (2024). Laparoscopic Extended Segmentectomy VIII Guided by Three-Dimensional Reconstruction and Hepatic Veins with a Cranio-Caudal Approach. Annals of Surgical Oncology. 31(10). 6567–6568. 2 indexed citations
3.
Dupré, Aurélien, Michel Rivoire, Claire Cropet, et al.. (2023). Intra-operative High-Intensity Focused Ultrasound in Patients With Colorectal Liver Metastases: A Prospective Ablate-and-Resect Study. Ultrasound in Medicine & Biology. 49(8). 1845–1851. 5 indexed citations
4.
Lafond, Maxime, et al.. (2022). Pancreatic Ductal Adenocarcinoma: Current and Emerging Therapeutic Uses of Focused Ultrasound. Cancers. 14(11). 2577–2577. 14 indexed citations
5.
Benoist, Stéphane, Patrick Devos, Stéphanie Truant, et al.. (2022). Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study. World Journal of Surgical Oncology. 20(1). 131–131. 15 indexed citations
6.
Fouchardière, Christelle de la, Pia Gamradt, Sylvie Chabaud, et al.. (2022). A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3. Journal of Personalized Medicine. 12(4). 623–623. 2 indexed citations
7.
Peyrat, Patrice, et al.. (2022). Curative‐intent treatment of pulmonary metastases from colorectal cancer: A comparison between imaging‐guided thermal ablation and surgery. Journal of Surgical Oncology. 127(1). 183–191. 4 indexed citations
8.
Challine, Alexandre, Christelle de la Fouchardière, Thierry André, et al.. (2022). Outcomes of surgical resection in microsatellite instable colorectal cancer after immune checkpoint inhibitor treatment. British journal of surgery. 110(9). 1043–1045. 2 indexed citations
9.
11.
Brahmi, Mehdi, Philippe A. Cassier, Armelle Dufresne, et al.. (2020). Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT). PLoS ONE. 15(5). e0233046–e0233046. 9 indexed citations
12.
Dupré, Aurélien, David Melodelima, David Pérol, et al.. (2019). Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases. Journal of Visualized Experiments. 4 indexed citations
14.
Phelip, Jean–Marc, David Tougeron, David Léonard, et al.. (2019). Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR). Digestive and Liver Disease. 51(10). 1357–1363. 70 indexed citations
15.
Peyrat, Patrice, Ellen Blanc, Céline Ferlay, et al.. (2018). HEPATOFLUO: A prospective monocentric study assessing the benefits of indocyanine green (ICG) fluorescence for hepatic surgery. Journal of Surgical Oncology. 117(5). 922–927. 20 indexed citations
16.
Dupré, Aurélien, Robert Jones, Alex Parker, et al.. (2018). Validation of clinical prognostic scores for patients treated with curative‐intent for recurrent colorectal liver metastases. Journal of Surgical Oncology. 117(6). 1330–1336. 14 indexed citations
17.
Dupré, Aurélien & Hassan Malik. (2018). Inflammation and cancer: What a surgical oncologist should know. European Journal of Surgical Oncology. 44(5). 566–570. 133 indexed citations
18.
Dupré, Aurélien, Robert Jones, Rafael Díaz-Nieto, et al.. (2017). Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection. European Journal of Surgical Oncology. 43(10). 1901–1907. 41 indexed citations
20.
Gagnière, Johan, Aurélien Dupré, Sylvie Chabaud, et al.. (2015). Retroperitoneal nodal metastases from colorectal cancer: Curable metastases with radical retroperitoneal lymphadenectomy in selected patients. European Journal of Surgical Oncology. 41(6). 731–737. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026